Title | Hematology, Transfusion and Cell Therapy |
Standard Abbreviation | Hematol. Transfus. Cell Ther. |
Type of Publication | Journal |
Discipline | Hematology (Q3); Immunology and Allergy (Q4) |
Impact Score | 1.36 |
SCImago Journal Rank (SJR) | 0.323 |
h-index | 29 |
Overall Rank | 14411 |
Publisher Name | Elsevier Editora Ltda |
Publication Country | Brazil |
International Standard Serial Number (ISSN) | 25311387, 25311379 |
Coverage and History | 2018-2022 |
Best Quartile | Q3 |
Total Citations Received (Last 3 Year) |
370 |
Hematology, Transfusion and Cell Therapy is a journal published by Elsevier Editora Ltda. This journal covers the area[s] related to Hematology, Immunology and Allergy, etc.
The coverage history of this journal is as follows: 2018-2022.
The rank of this journal is 14411. This journal's impact score, h-index, and SJR are 1.36, 29, and 0.323, respectively. The ISSN of this journal is/are as follows: 25311387, 25311379.
The best quartile of Hematology, Transfusion and Cell Therapy is Q3.
This journal has received a total of 370 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Hematology, Transfusion and Cell Therapy is 1.36. It is computed in the year 2023 as per its definition and based on Scopus data.
1.36
It is decreased by a factor of around 0.31, and the percentage change is -18.56% compared to the preceding year 2021, indicating a falling trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of Hematology, Transfusion and Cell Therapy is 1.36. If a similar downward trend continues, IS may decrease in 2023 as well.
Year | Impact Score (IS) |
---|---|
2023/2024 | Coming Soon |
2022 | 1.36 |
2021 | 1.67 |
2020 | 1.06 |
2019 | 0.77 |
2018 | 0.72 |
2017 | 0.74 |
2016 | 0.76 |
2015 | 0.61 |
2014 | 0.56 |
The h-index of Hematology, Transfusion and Cell Therapy is 29. By definition of the h-index, this journal has at least 29 published articles with more than 29 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Hematology, Transfusion and Cell Therapy is/are as follows: 25311387, 25311379.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Hematology, Transfusion and Cell Therapy is ranked 14411 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 0.323.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Hematology, Transfusion and Cell Therapy is Elsevier Editora Ltda. The publishing house of this journal is located in the Brazil. Its coverage history is as follows: 2018-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of Hematology, Transfusion and Cell Therapy is Hematol. Transfus. Cell Ther.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).
As ISO 4 is an international standard, the abbreviation ('Hematol. Transfus. Cell Ther.') can be used for citing, indexing, abstraction, and referencing purposes.
If your area of research or discipline is related to Hematology, Immunology and Allergy, etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Hematology, Transfusion and Cell Therapy is 1.36. It is computed in the year 2023.
The latest h-index of Hematology, Transfusion and Cell Therapy is 29. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of Hematology, Transfusion and Cell Therapy is 0.323. It is calculated in the year 2023.
The latest ranking of Hematology, Transfusion and Cell Therapy is 14411. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Hematology, Transfusion and Cell Therapy is published by Elsevier Editora Ltda. The publication country of this journal is Brazil.
This standard abbreviation of Hematology, Transfusion and Cell Therapy is Hematol. Transfus. Cell Ther..
Hematology, Transfusion and Cell Therapy is a journal published by Elsevier Editora Ltda.
The scope of Hematology, Transfusion and Cell Therapy is as follows:
For detailed scope of Hematology, Transfusion and Cell Therapy, check the official website of this journal.
The International Standard Serial Number (ISSN) of Hematology, Transfusion and Cell Therapy is/are as follows: 25311387, 25311379.
The best quartile for Hematology, Transfusion and Cell Therapy is Q3.
The coverage history of Hematology, Transfusion and Cell Therapy is as follows 2018-2022.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
---|---|---|---|---|---|---|
Clinical Medicine and Research | Journal | Marshfield Clinic | 16602 | 60 | 1.06 | |
Current Sociology | Journal | SAGE Publications Ltd | 6591 | 76 | 2.29 | |
International Journal of Mathematical Education in Science and Technology | Journal | Taylor and Francis Ltd. | 10040 | 39 | 1.33 | |
Archives of Phytopathology and Plant Protection | Journal | Taylor and Francis Ltd. | 14852 | 29 | 1.14 | |
Journal of Classical Sociology | Journal | SAGE Publications Ltd | 13766 | 27 | 0.83 | |
Child and Family Social Work | Journal | Wiley-Blackwell Publishing Ltd | 8628 | 67 | 2.20 | |
Marine Biology Research | Journal | Taylor and Francis Ltd. | 13573 | 42 | 1.06 | |
International Journal of Research and Method in Education | Journal | Taylor and Francis Ltd. | 5180 | 34 | 2.49 | |
Howard Journal of Communications | Journal | Taylor and Francis Ltd. | 9564 | 36 | 1.66 | |
Acta Periodica Technologica | Journal | University of Novi Sad, Faculty of Technology | 19470 | 18 | 0.62 |
Year | Impact Score (IS) |
---|---|
2023/2024 | Updated Soon |
2022 | 1.36 |
2021 | 1.67 |
2020 | 1.06 |
2019 | 0.77 |
2018 | 0.72 |
2017 | 0.74 |
2016 | 0.76 |
2015 | 0.61 |
2014 | 0.56 |